A review of synbiotic efficacy in non-alcoholic fatty liver disease as a therapeutic approach
- 1 September 2019
- journal article
- review article
- Published by Elsevier in Diabetes & Metabolic Syndrome: Clinical Research & Reviews
- Vol. 13 (5) , 2917-2922
Abstract
No abstract availableKeywords
This publication has 54 references indexed in Scilit:
- Richness of human gut microbiome correlates with metabolic markersNature, 2013
- The potential role of prebiotic fibre for treatment and management of non‐alcoholic fatty liver disease and associated obesity and insulin resistanceLiver International, 2011
- Energy-balance studies reveal associations between gut microbes, caloric load, and nutrient absorption in humansThe American Journal of Clinical Nutrition, 2011
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- The gut microbiota modulates host energy and lipid metabolism in miceJournal of Lipid Research, 2010
- Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease†Hepatology, 2009
- A core gut microbiome in obese and lean twinsNature, 2008
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Nonalcoholic Fatty Liver Disease: From Steatosis to CirrhosisHepatology, 2006
- Signalling links in the liver: Knitting SOCS with fat and inflammationJournal of Hepatology, 2005